SG Americas Securities’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,158
| Closed | -$106K | – | 3090 |
|
|
2025
Q1 | $106K | Buy |
+7,158
| New | +$106K | ﹤0.01% | 2669 |
|
|
2024
Q2 | – | Sell |
-16,099
| Closed | -$224K | – | 2825 |
|
|
2024
Q1 | $224K | Buy |
16,099
+824
| +5% | +$11.5K | ﹤0.01% | 1677 |
|
|
2023
Q4 | $218K | Sell |
15,275
-768
| -5% | -$11K | ﹤0.01% | 1889 |
|
|
2023
Q3 | $248K | Buy |
16,043
+6,775
| +73% | +$105K | ﹤0.01% | 1993 |
|
|
2023
Q2 | $146K | Hold |
9,268
| – | – | ﹤0.01% | 1678 |
|
|
2023
Q1 | $153K | Buy |
+9,268
| New | +$153K | ﹤0.01% | 2395 |
|
|
2022
Q2 | – | Sell |
-9,729
| Closed | -$139K | – | 3181 |
|
|
2022
Q1 | $139K | Sell |
9,729
-14,701
| -60% | -$210K | ﹤0.01% | 2343 |
|
|
2021
Q4 | $333K | Hold |
24,430
| – | – | ﹤0.01% | 2160 |
|
|
2021
Q3 | $400K | Sell |
24,430
-39
| -0.2% | -$639 | ﹤0.01% | 2482 |
|
|
2021
Q2 | $412K | Sell |
24,469
-8,914
| -27% | -$150K | ﹤0.01% | 1836 |
|
|
2021
Q1 | $610K | Buy |
33,383
+8,915
| +36% | +$163K | ﹤0.01% | 1703 |
|
|
2020
Q4 | $445K | Hold |
24,468
| – | – | ﹤0.01% | 1812 |
|
|
2020
Q3 | $437K | Sell |
24,468
-4
| -0% | -$71 | ﹤0.01% | 1438 |
|
|
2020
Q2 | $439K | Buy |
24,472
+200
| +0.8% | +$3.59K | ﹤0.01% | 1883 |
|
|
2020
Q1 | $368K | Sell |
24,272
-25
| -0.1% | -$379 | ﹤0.01% | 1717 |
|
|
2019
Q4 | $479K | Buy |
24,297
+4
| +0% | +$79 | ﹤0.01% | 1581 |
|
|
2019
Q3 | $418K | Buy |
24,293
+146
| +0.6% | +$2.51K | ﹤0.01% | 1723 |
|
|
2019
Q2 | $427K | Buy |
24,147
+1,785
| +8% | +$31.6K | ﹤0.01% | 1725 |
|
|
2019
Q1 | $456K | Buy |
+22,362
| New | +$456K | ﹤0.01% | 1687 |
|